2025 annual financial data
NRX Pharmaceuticals 2025 Operating margin
Direct answer
Operating margin was -1,324.41%.
Operating income was -16,224,000 USD and net income was -28,622,000 USD.
Operating cash flow was -14,112,000 USD.
Get free NRX Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,225,000 USD
- Operating income
- -16,224,000 USD
- Net income
- -28,622,000 USD
- Operating cash flow
- -14,112,000 USD